摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-氯-3-乙氧基苯胺 | 852854-42-3

中文名称
4-氯-3-乙氧基苯胺
中文别名
——
英文名称
4-chloro-3-ethoxyaniline
英文别名
——
4-氯-3-乙氧基苯胺化学式
CAS
852854-42-3
化学式
C8H10ClNO
mdl
——
分子量
171.626
InChiKey
JQQWIIGQFDFTCS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    35.2
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2922299090

SDS

SDS:e8c18fea605b22a2f06dfe5e9a80e9f2
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-Chloro-3-ethoxyaniline
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 4-Chloro-3-ethoxyaniline
CAS number: 852854-42-3

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H10ClNO
Molecular weight: 171.6

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-氯-3-乙氧基苯胺盐酸乙醇 、 sodium hydroxide 、 sodium nitrite 作用下, 以 为溶剂, 反应 4.5h, 生成 4-chloro-3-ethoxybenzenethiol
    参考文献:
    名称:
    [EN] NTCP INHIBITORS
    [FR] INHIBITEURS DE NTCP
    摘要:
    提供的环孢霉素A类似物是NTCP抑制剂,可用于治疗HBV和/或HDV感染,肝脏保护和改善高胆固醇血症、糖尿病以及抑制癌症。
    公开号:
    WO2019196953A1
  • 作为产物:
    描述:
    1-氯-2-乙氧基-4-硝基苯铁粉溶剂黄146 作用下, 以 为溶剂, 反应 2.5h, 以100%的产率得到4-氯-3-乙氧基苯胺
    参考文献:
    名称:
    [EN] NTCP INHIBITORS
    [FR] INHIBITEURS DE NTCP
    摘要:
    提供的环孢霉素A类似物是NTCP抑制剂,可用于治疗HBV和/或HDV感染,肝脏保护和改善高胆固醇血症、糖尿病以及抑制癌症。
    公开号:
    WO2019196953A1
点击查看最新优质反应信息

文献信息

  • Development of 2-Thioxoquinazoline-4-one Derivatives as Dual and Selective Inhibitors of Dynamin-Related Protein 1 (Drp1) and Puromycin-Sensitive Aminopeptidase (PSA)
    作者:Akiyoshi Numadate、Yusuke Mita、Yotaro Matsumoto、Shinya Fujii、Yuichi Hashimoto
    DOI:10.1248/cpb.c14-00333
    日期:——
    An established inhibitor of dynamin-related protein 1 (Drp1), 3-(2,4-dichloro-5-methoxyphenyl)-2-thioxoquinazoline-4-one (mdivi-1), was recently reported also to show potent puromycin-sensitive aminopeptidase (PSA)-inhibitory activity. Herein, we report structural development of mdivi-1 derivatives and structure–activity relationship (SAR) analysis of the synthesized compounds, as well as the structurally related PSA-specific inhibitor 3-(2,6-diethylphenyl)quinazoline-2,4-dione (PAQ-22), with the aim of identifying key structural features for inhibitory activity in order to develop selective inhibitors of Drp1, which is a potential target for treatment of Huntington’s disease. Among the synthesized compounds, 3-(4-chloro-3-methoxyphenyl)-2-thioxoquinazoline-4-one (10g) exhibited more potent Drp1-inhibitory activity than mdivi-1 with high selectivity for Drp1 over PSA.
    已知的dynamin相关蛋白1(Drp1)抑制剂——3-(2,4-二-5-甲氧苯基)-2-噻唑啉酮(mdivi-1),近期还被报道显示出强大的嘌呤霉素敏感性氨基肽酶(PSA)抑制活性。在此,我们报道了mdivi-1衍生物的结构开发、合成化合物的构效关系(SAR)分析,以及结构相关的PSA特异性抑制剂3-(2,6-二乙基苯基)喹唑啉-2,4-二酮(PAQ-22),旨在识别抑制活性的关键结构特征,从而开发针对Drp1的选择性抑制剂,Drp1是治疗亨廷顿病的潜在靶点。在合成化合物中,3-(4--3-甲氧苯基)-2-噻唑啉酮(10g)表现出比mdivi-1更强大的Drp1抑制活性,并对Drp1显示出高度选择性优于PSA
  • [EN] POTENT DUAL BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS<br/>[FR] PUISSANTS DOUBLES INHIBITEURS DE BRD4 ET DE KINASE À UTILISER EN TANT QU'AGENTS THÉRAPEUTIQUES ANTICANCÉREUX
    申请人:H LEE MOFFITT CANCER CT & RES
    公开号:WO2016022460A1
    公开(公告)日:2016-02-11
    Disclosed herein are compounds that are inhibitors of BRD4 and their use in the treatment of cancer. Methods of screening for selective inhibitors of BRD4 are also disclosed. In certain aspects, disclosed are compounds of Formula I-IV.
    本文披露了一些抑制BRD4的化合物及其在癌症治疗中的应用。还披露了筛选BRD4选择性抑制剂的方法。在某些方面,披露了Formula I-IV的化合物。
  • [EN] BICYCLIC PYRIMIDIN-4-(3H)-ONES AND ANALOGUES AND DERIVATIVES THEREOF WHICH MODULATE THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1)<br/>[FR] PYRIMIDINE-4-(3H)-ONES BICYCLIQUES, LEURS ANALOGUES ET DERIVES MODULANT LA FONCTION DU RECEPTEUR DE VANILLOIDE-1 (VR1)
    申请人:MERCK SHARP & DOHME
    公开号:WO2005049613A1
    公开(公告)日:2005-06-02
    Compounds of formula (I); which are useful as therapeutic compounds, particularly in the treatment of pain and other conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1).
    式(I)的化合物;这些化合物在治疗疼痛和其他通过调节辣椒素-1受体(VR1)功能而改善的症状方面特别有用。
  • [EN] BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS<br/>[FR] INHIBITEURS DE BRD4-KINASE À UTILISER EN TANT QU'AGENTS THÉRAPEUTIQUES ANTICANCÉREUX
    申请人:H LEE MOFFITT CANCER CENTER & RES INST INC
    公开号:WO2017066428A1
    公开(公告)日:2017-04-20
    Disclosed herein are compounds that are inhibitors of BDR4 and their use in the treatment of cancer. Methods of screening for selective inhibitors of BDR4 are also disclosed. In certain aspects, disclosed are compounds of Formula I through IV.
    本文披露了一些抑制BDR4的化合物及其在癌症治疗中的应用。还披露了筛选BDR4选择性抑制剂的方法。在某些方面,披露了公式I至IV的化合物。
  • NOVEL HETEROCYCLIC COMPOUNDS AS PESTICIDES
    申请人:Bayer CropScience Aktiengesellschaft
    公开号:US20200062729A1
    公开(公告)日:2020-02-27
    The invention relates to novel compounds of the formula (I) in which Z, Y, A 1 , A 2 , A 3 , A 4 , X, R 7 , R 8 and R 9 have the meanings mentioned above, and processes and intermediates for the preparation thereof, and their use for controlling animal pests, in particular insects.
    该发明涉及公式(I)中的新化合物,其中Z、Y、A1、A2、A3、A4、X、R7、R8和R9具有上述提及的含义,以及其制备的过程和中间体,以及它们用于控制动物害虫,特别是昆虫。
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯